Trial Site Detail
Drug: |
Nilotinib or Imatinib |
|||
|---|---|---|---|---|
Trial: |
Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg (LANGIST) |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Terminated |
|||
QE II Health Sciences Center |
Principal Investigator: |
|
|---|---|
Contact: |
|
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
QE II Health Sciences Center Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.